CD44 and cancer: Another evidence-synthesis study based on 5788 cancer patients indicated that CD44 polymorphism rs13347 acts as a risk factor for cancer, especially in Chinese people, while the minor allele of polymorphism rs11821102 may be associated with a decreased susceptibility to cancer [79].